COMPARE OPTIONS

Last Updated: March 17, 2026

Mindbloom vs Innerwell: The Full Comparison Guide

This guide compares Mindbloom and Innerwell across the factors that matter most when choosing an at-home ketamine therapy provider: care model, administration options, published clinical evidence, cost, and safety protocols.

Key takeaways

  • Innerwell pairs clinician-managed ketamine with access to licensed therapists offering talk therapy and EMDR; Mindbloom pairs clinician oversight with a dedicated guide who specializes in ketamine preparation and integration, plus guide-facilitated Group Integration Circles.
  • Mindbloom offers sublingual tablets and subcutaneous injectables; Innerwell offers sublingual tablets.
  • Innerwell's eight-session program is generally $924 to $998, and some insurance plans are accepted; Mindbloom's six-session program is $1,290 and is HSA/FSA eligible, with no direct insurance billing.
  • Mindbloom has published three peer-reviewed studies on outcomes from its own clients, including one of 1,247 clients using sublingual tablets in which 89% reported improvement in their depression and anxiety symptoms after four sessions (Hull et al., 2022); Innerwell has not published peer-reviewed research on its own protocol.

Updated August 2026: Innerwell Has Closed

Innerwell notified patients that its final day of patient care was August 31, 2026. The comparison below describes Innerwell's program as it operated before closing, and is kept online as a record for former Innerwell patients and for anyone researching how the two providers compared.

If you were an Innerwell patient: request your medical records through the request link on Innerwell's closing notice, and make sure you have your exact prescribed dose, route of administration, and session count before you establish care elsewhere. A new provider will need all of it. If you are partway through a program, talk to a clinician about timing rather than simply stopping. Mindbloom accepts patients who previously received care from another at-home ketamine provider.

Source: Innerwell closing notice, archived August 25, 2026.

Mindbloom vs Innerwell at a Glance

Both Mindbloom and Innerwell are leading providers of at-home ketamine therapy for depression, anxiety, and PTSD. They differ significantly in their clinical frameworks, published evidence, administration options, and pricing. This quick-reference table highlights the core differences before exploring each provider in detail.

Feature Mindbloom Innerwell
Accepting new patients Yes No. Closed August 31, 2026
Care model Defined treatment framework (clinician + guide coaching + integration circles) Ketamine paired with optional talk therapy and EMDR
Administration options Sublingual tablets and subcutaneous injectables Sublingual tablets
Published research on own protocol Yes (three peer-reviewed studies: two in the Journal of Affective Disorders, one in the Journal of Medical Internet Research) No published outcomes data on own protocol
Sessions per program 6, 12, or 18 sessions 8 or 24 sessions
Approximate cost $1,290 for 6 sessions ~$924–$998 for 8 sessions
State availability 38 states Multi-state telehealth
Integration support 1:1 coaching with a ketamine-specialist guide + unlimited guide-facilitated Group Integration Circles Therapy sessions (talk therapy, EMDR)
App and session tools Mindbloom App with soundscapes, preparation, and integration content Patient portal
Subcutaneous option Yes (only at-home provider offering this) No
Insurance HSA/FSA eligible; no direct insurance billing Some insurance accepted

What Is Mindbloom

Mindbloom is one of the largest providers of guided at-home ketamine therapy in the United States. As of October 2026, it has facilitated more than 900,000 sessions. The company delivers protocol-driven programs that pair clinician-prescribed ketamine with dedicated coaching, integration support, and an engaged community.

The Mindbloom care model is designed to provide a comprehensive therapeutic process rather than just medication delivery. Patients frequently highlight this comprehensive support system.

The experience includes several core components:

  • Clinician oversight: Licensed psychiatric clinicians conduct a thorough intake evaluation, prescribe the medication, and manage dosing throughout the program.
  • Guide coaching: Each client is paired with a dedicated guide for one-on-one preparation and integration sessions to help process the experience.
  • Group Integration Circles: Clients receive unlimited access to guide-facilitated group integration sessions to share insights and build community.
  • Bloombox: A physical kit is shipped to the client containing a blood pressure monitor, journal, eye mask, and other session essentials.
  • Mindbloom App: The proprietary Mindbloom app guides sessions with custom soundscapes, preparation content, and integration journaling.
  • Administration options: Clients can choose between sublingual tablets and Mindbloom injectables (subcutaneous administration).

Pros of Mindbloom:

  • Comprehensive care model with clinician oversight, guide coaching, and community support
  • Only at-home provider offering subcutaneous injectables
  • Three peer-reviewed studies published on its specific clinical protocol
  • Available in 38 states

Cons of Mindbloom:

  • Higher per-program cost than some competitors
  • No talk therapy or EMDR; clients can keep their own therapist alongside
  • No direct insurance billing, though HSA/FSA funds are eligible and a Superbill is provided for potential partial reimbursement

Mindbloom's six-session new client program is $430/month over three months ($1,290 total). Twelve- and eighteen-session programs are also available at lower per-session rates — as low as $330/month over 9 months for an 18-session program.

What Is Innerwell

Innerwell is an online ketamine treatment provider that combines at-home ketamine therapy with access to licensed therapists. The company focuses on integrating traditional psychotherapy modalities with psychedelic medicine.

The Innerwell experience is built around flexibility and therapeutic integration. When looking at Innerwell reviews, clients often appreciate the ability to work directly with licensed mental health professionals. Innerwell may appeal to individuals who specifically want licensed talk therapy or EMDR integrated directly into their ketamine treatment plan.

The program includes the following elements:

  • Clinical model: Clients undergo a psychiatric evaluation and receive prescription management via telehealth, with sublingual ketamine tablets shipped for at-home use.
  • Therapy integration: Innerwell offers licensed talk therapy and EMDR (Eye Movement Desensitization and Reprocessing) alongside ketamine treatment.
  • Session structure: Programs typically include 8 or 24 sessions.
  • Session support: The company recommends having a support person present during sessions.
  • Availability: Innerwell is a multi-state telehealth service.

Pros of Innerwell:

  • Optional talk therapy and EMDR alongside ketamine sessions
  • Lower cost per session compared to some other providers
  • Accepts some insurance plans to help offset costs
  • Flexible session counts with 8 or 24-session options

Cons of Innerwell:

  • No published peer-reviewed research on its own specific protocol
  • Sublingual tablets only

Innerwell cost is generally around $924 to $998 for an eight-session program. For those using accepted insurance, the cost can be approximately $599, and 24-session plans are available for extended care.

Comparing Care Models for Mindbloom and Innerwell

A care model refers to the full framework of clinical oversight, therapeutic support, and integration that surrounds the ketamine sessions themselves. It encompasses everything from preparation to the post-session transition, ensuring the medication is part of a broader healing process.

Mindbloom's Guided Program Model

Mindbloom utilizes a highly supported, protocol-driven approach to care. Every Mindbloom client works with a dedicated guide, a trained psychedelic integration specialist who helps them prepare for each session and turn what comes up into lasting change. Guides are hired with a coaching certification or 500+ hours of coaching experience with 50+ clients, complete Mindbloom's training protocol, and about 75% hold two or more certifications in areas like trauma healing or addiction recovery. Guides are part of a care team led by licensed clinicians, who handle evaluation, prescribing, and dosing, and guides share safety and progress updates with them. Mindbloom's peer-reviewed outcomes come from clients receiving this same clinician-and-guide care.

Innerwell's Therapy Integrated Model

Innerwell builds its program around traditional psychotherapy. Psychiatric evaluation and prescription management are handled via telehealth, and ketamine sessions take place at home using sublingual tablets.

Its defining feature is access to licensed therapists offering talk therapy and EMDR alongside ketamine treatment, positioning the company as a bridge between conventional therapy and psychedelic medicine. Programs typically include 8 or 24 sessions, with clinician-guided dosing that may start conservatively and adjust over time.

Administration Methods and Dosing Differences

Administration method refers to how ketamine is delivered into the body. The most common routes are sublingual (a tablet held in the mouth), subcutaneous (a small injection), intravenous (IV infusion), or intranasal.

Each route offers different bioavailability, onset times, and session characteristics. Higher bioavailability doesn't by itself mean better outcomes. Sublingual ketamine absorbs at about 30% (Rolan et al., 2014) and IV at close to 100%, yet published depression response is comparable: 56.4% for Mindbloom clients by session 4 (Mathai 2024) vs. 53.6% for IV (McInnes 2022). Bioavailability is how much of a dose reaches the bloodstream, and doses are calibrated to each route.

Mindbloom offers two distinct administration routes to accommodate different patient needs:

  • Sublingual tablets: These are held between the cheek and gums for seven minutes before the effects begin within 10 to 15 minutes. This needle-free option is convenient, with your dose set by your clinician and adjusted between sessions as needed.
  • Subcutaneous injectables: Administered via a small insulin needle into the abdomen, effects begin in about five minutes. This route gives clients an alternative to tablets if they prefer injections, want more flexibility, or tried tablets and didn't like them.

Mindbloom is the only at-home provider offering this subcutaneous option, while Innerwell offers sublingual tablets. Both providers utilize clinician-determined, sub-anesthetic therapeutic dosing, and Mindbloom personalizes the treatment frequency based on clinical guidance and individual response. For a broader look at how these routes compare with in-clinic care, see at-home ketamine vs infusion clinics.

Published Research and Clinical Evidence

Published research on a provider's own protocol means that peer-reviewed studies have evaluated outcomes specifically from that provider's patients. Its results describe that provider's own clients, rather than general ketamine research applied by association.

Mindbloom has published three peer-reviewed, real-world outcomes studies of at-home ketamine therapy. The first study, Hull et al. (2022), was published in the Journal of Affective Disorders and evaluated the safety and effectiveness of Mindbloom's sublingual ketamine protocol.

The second study, Mathai et al. (2024), also published in the Journal of Affective Disorders, represents the largest published study of at-home ketamine therapy outcomes to date. The third, Parks et al. (2026), published in the Journal of Medical Internet Research, is the first peer-reviewed study of at-home subcutaneous ketamine, including PTSD outcomes. Mindbloom has also released a sleep outcomes preprint.

Innerwell does not currently have published peer-reviewed research evaluating outcomes from its own clinical protocol and often references Mindbloom's peer-reviewed studies to support its own safety and efficacy positioning. This does not mean Innerwell's treatment is ineffective, as ketamine's therapeutic evidence base is well-established across decades of research. However, it does mean that prospective patients cannot evaluate Innerwell-specific outcomes from peer-reviewed data and should be aware that outcomes from one provider's protocol do not automatically transfer to another.

Cost Insurance and Accessibility

Cost comparison for at-home ketamine therapy requires looking beyond the sticker price. A thorough evaluation should account for the per-session price, what is included in that price, and whether insurance or HSA/FSA funds can be applied.

Mindbloom's six-session new client program is $430/month over three months ($1,290 total), which includes 2 clinician consults, 6 sessions with medicine, 3 guide coaching sessions plus unlimited messaging, unlimited Group Integration Circles, the Bloombox, and full app access. Twelve-session ($370/month over 6 months) and eighteen-session ($330/month over 9 months) programs are also available at a lower per-session cost.

Returning client programs of 6 or 18 sessions are available at preferred rates for continuing clients. While Mindbloom does not bill insurance directly, all programs are HSA/FSA eligible, and clients receive a Superbill after completing treatment — an itemized receipt that can be submitted to their insurance provider for potential partial reimbursement.

Innerwell pricing is generally $924 to $998 for an eight-session program, which can drop to approximately $599 with insurance. They also offer 24-session plans at a lower per-session cost.

Accepted insurance can lower costs for eligible clients. However, applicable insurance coverage primarily applies to standard psychiatry or therapy visits — in many cases, the ketamine medication, dosing sessions, and program fees remain out-of-pocket. Meaningful insurance coverage is largely limited to select plans in certain states, and therapy sessions may be billed separately.

Safety and Screening Protocols

Safety in at-home ketamine therapy is a function of clinical screening, defined treatment frameworks, ongoing oversight, and in-session monitoring. It is not determined by dose size or setting alone. Ketamine itself has been FDA-approved as an anesthetic since 1970 and has been on the World Health Organization List of Essential Medicines since 1985. Mindbloom's model builds directly on this established clinical foundation.

A robust safety protocol requires evaluating a patient's full medical and psychiatric history before treatment begins. This ensures the medication is medically appropriate and identifies any potential contraindications.

Mindbloom's safety protocols begin with comprehensive medical and psychiatric screening during the intake process, and doses are adjusted on an ongoing basis according to the patient's response. A peer treatment monitor, a friend or family member you choose, is required to be present in your home during every session. Your Mindbloom guide walks them through the process and gives them the information and resources they need to feel comfortable in the role. They stay in a nearby room, checking in about every 15 minutes. Mindbloom also has clear escalation protocols, including an on-call clinician.

Innerwell's safety protocols also start with a thorough psychiatric evaluation during intake. Prescribing and dosing are managed by licensed clinicians, and the company recommends having a support person present during sessions. Both providers conduct rigorous medical screening and utilize clinician oversight to mitigate potential risks.

Mindbloom Outcomes What the Published Research Shows

In a peer-reviewed study of 11,441 Mindbloom clients (Mathai et al., 2024), the largest published study of at-home ketamine therapy, 56.4% met response criteria for depression and 28.1% reached remission on the PHQ-9 by session 4; among the 7,776 with baseline anxiety scores, 56.1% met response criteria and 28.8% reached remission on the GAD-7. Mindbloom's depression response rate is within the range reported in SSRI antidepressant studies (Stone M et al., 2022) and about 38% higher than the roughly 41% reported for psychotherapy (Cuijpers P et al., 2021), reached faster, though the studies used separate populations and different designs. In Mindbloom's earlier study of 1,247 clients (Hull et al., 2022), 89% reported improvement in their symptoms after four sessions.

For PTSD, a peer-reviewed study of at-home subcutaneous ketamine (Parks et al., 2026) found that by the end of the six-session course, 76.7% of clients met response criteria on the PCL-5, 56.7% reached remission, and 84.6% saw clinically meaningful improvement. Mindbloom's PTSD response and remission (76.7% and 56.7% by the end of the six-session course) are comparable to or slightly exceeding the rates reported for intensive trauma therapy (about 72–76% response and about 54% loss of diagnosis; Held P et al., 2020; Dell L et al., 2023), reached in about six sessions instead of a three-to-four-month course, though the comparator studies used intensive-format veteran and military cohorts.

For sleep, a retrospective analysis of 13,963 clients (Swain J et al., 2026, preprint) found that 77% of those who completed six sessions met response criteria for sleep, with a 49% average reduction in sleep disturbances. Only 2.5% reported worsened sleep.

In Mathai et al. (2024), side effects were reported in approximately 4-5% of participants, and serious adverse events occurred in fewer than 0.1% of participants. Individual results may vary; these results come from Mindbloom's own clients.

Which At Home Ketamine Program Is Right for You

Choosing between Innerwell and Mindbloom depends on your clinical needs, personal preferences, and financial circumstances. Both offer clinician-led at-home ketamine care models, so the most appropriate option comes down to the kind of support you want and your treatment goals.

Mindbloom may be right for you if:

  • You want a clinically managed experience with built-in coaching and integration.
  • You already see a therapist and want to keep them while working with a Mindbloom guide.
  • Published, peer-reviewed outcomes data from a provider's own clients matters to you.
  • You want subcutaneous injections as an alternative to tablets, for example if you prefer injections or tried tablets and didn't like them.
  • You value community support through Group Integration Circles.
  • You are located in one of the 38 states where Mindbloom operates.

Innerwell may be right for you if:

  • You do not have a therapist already and/or want talk therapy or EMDR bundled into your ketamine program.
  • Using insurance for part of your care is a primary financial priority.
  • You prefer a lower per-session cost.
  • You prefer to start with lower doses and titrate gradually.

Disclaimer and Safety Information

IMPORTANT SAFETY INFORMATION
‍
Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary.Full safety information: www.mindbloom.com/safety-information‍

‍OFF-LABEL USE DISCLOSURE
‍
Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.

Frequently asked questions

Is Innerwell still in business?

No. Innerwell closed on August 31, 2026, and has published a closing notice on its website. Former patients who want to continue ketamine therapy will need to establish care with a new licensed provider, who will conduct a new medical evaluation. Request your treatment records from Innerwell first, including your diagnosis, prescribed dose, route of administration, and session count, so your new clinician can set your dose from your actual regimen rather than a default.

Which is more affordable Mindbloom or Innerwell?

Innerwell's per-session cost is generally lower, and some insurance is accepted. Mindbloom's program pricing includes 1:1 coaching with a guide who specializes in ketamine preparation and integration, guide-facilitated integration circles, and app access, none of which are bundled in Innerwell's base cost.

Does Innerwell have published research on its own protocol?

Innerwell does not currently have peer-reviewed studies evaluating outcomes from its own clinical protocol. Mindbloom has published three peer-reviewed studies on its own patient population: two in the Journal of Affective Disorders and one in the Journal of Medical Internet Research.

Can you switch from Innerwell to Mindbloom?

Yes, if you have previously used another at-home ketamine provider, you can enroll in Mindbloom as a new client. Your clinician will evaluate your treatment history during the intake process.

Does Mindbloom accept insurance?

Mindbloom does not bill insurance directly but is HSA/FSA eligible. Innerwell accepts some insurance plans, which may reduce the out-of-pocket cost for eligible patients.

What is the difference between Mindblooms tablets and injectables?

Sublingual tablets are held in the mouth and are needle-free, while subcutaneous injectables use a small insulin needle and give clients an alternative to tablets if they prefer injections, want more flexibility, or tried tablets and didn't like them. Mindbloom is the only at-home provider offering both options.

Do you need a prescription for at home ketamine therapy?

Yes. A licensed clinician must determine that ketamine is medically appropriate and prescribe it. Both Mindbloom and Innerwell require a thorough psychiatric evaluation before a clinician will write a prescription for treatment.

Mindbloom Treatment

HSA/FSA ELIGIBLE
4.7/5

See what might be possible with clinician-guided, at-home ketamine therapy. New client programs start at $165 per session.

Get started

Keep us top of mind in your inbox.

Thank you! You're now registered!
Oops! Something went wrong while submitting the form.

In this article

Text 1
0 References

Authors

Explore related articles

No items found.